203 related articles for article (PubMed ID: 26893685)
21. MiR-147b influences vascular smooth muscle cell proliferation and migration via targeting YY1 and modulating Wnt/β-catenin activities.
Yue Y; Lv W; Zhang L; Kang W
Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):905-913. PubMed ID: 30060075
[TBL] [Abstract][Full Text] [Related]
22. A data-driven biocomputing pipeline with meta-analysis on high throughput transcriptomics to identify genome-wide miRNA markers associated with type 2 diabetes.
De Silva K; Demmer RT; Jönsson D; Mousa A; Forbes A; Enticott J
Heliyon; 2022 Feb; 8(2):e08886. PubMed ID: 35169647
[TBL] [Abstract][Full Text] [Related]
23. MiR-142-5p Suppresses Lung Cancer Cell Metastasis by Targeting Yin Yang 1 to Regulate Epithelial-Mesenchymal Transition.
Zhang Q; Liu H; Zhang J; Shan L; Yibureyimu B; Nurlan A; Aerxiding P; Luo Q
Cell Reprogram; 2020 Dec; 22(6):328-336. PubMed ID: 33270501
[TBL] [Abstract][Full Text] [Related]
24. Identification of novel circulating miRNAs biomarkers for healthy obese and lean children.
Ma F; Cao D; Liu Z; Li Y; Ouyang S; Wu J
BMC Endocr Disord; 2023 Oct; 23(1):238. PubMed ID: 37904219
[TBL] [Abstract][Full Text] [Related]
25. Deregulated miRNAs Contribute to Silencing of B-Cell Specific Transcription Factors and Activation of NF-κB in Classical Hodgkin Lymphoma.
Paczkowska J; Janiszewska J; Ustaszewski A; Bein J; Skalski M; Dzikiewicz-Krawczyk A; Rozwadowska N; Hansmann ML; Hartmann S; Giefing M
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34201504
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA expression signatures of bladder cancer revealed by deep sequencing.
Han Y; Chen J; Zhao X; Liang C; Wang Y; Sun L; Jiang Z; Zhang Z; Yang R; Chen J; Li Z; Tang A; Li X; Ye J; Guan Z; Gui Y; Cai Z
PLoS One; 2011 Mar; 6(3):e18286. PubMed ID: 21464941
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-7 Regulates Migration and Chemoresistance in Non-Hodgkin Lymphoma Cells Through Regulation of KLF4 and YY1.
Morales-Martinez M; Vega GG; Neri N; Nambo MJ; Alvarado I; Cuadra I; Duran-Padilla MA; Huerta-Yepez S; Vega MI
Front Oncol; 2020; 10():588893. PubMed ID: 33194748
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-411-3p motivates methotrexate's cellular uptake and cytotoxicity via targeting Yin-yang 1 in leukemia cells.
Sun H; Zhou S; Yang Z; Meng M; Dai Y; Li X; Chen X
Acta Biochim Pol; 2023 Sep; 70(3):721-727. PubMed ID: 37724778
[TBL] [Abstract][Full Text] [Related]
29. The role of miRNAs in regulation of platelet activity and related diseases - a bioinformatic analysis.
Wicik Z; Czajka P; Eyileten C; Fitas A; Wolska M; Jakubik D; von Lewinski D; Sourij H; Siller-Matula JM; Postula M
Platelets; 2022 Oct; 33(7):1052-1064. PubMed ID: 35285386
[TBL] [Abstract][Full Text] [Related]
30. Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma.
Liu Q; Chen J; Wang J; Amos C; Killary AM; Sen S; Wei C; Frazier ML
Mol Carcinog; 2014 Sep; 53(9):711-21. PubMed ID: 23661430
[TBL] [Abstract][Full Text] [Related]
31. Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer.
Song B; Du J; Song DF; Ren JC; Feng Y
Biol Res; 2018 Nov; 51(1):44. PubMed ID: 30390708
[TBL] [Abstract][Full Text] [Related]
32. Identification of eight key miRNAs associated with renal cell carcinoma: A meta-analysis.
Ying G; Wu R; Xia M; Fei X; He QE; Zha C; Wu F
Oncol Lett; 2018 Nov; 16(5):5847-5855. PubMed ID: 30344735
[TBL] [Abstract][Full Text] [Related]
33. YY1 regulates melanoma tumorigenesis through a miR-9 ~ RYBP axis.
Zhao G; Li Q; Wang A; Jiao J
J Exp Clin Cancer Res; 2015 Jun; 34(1):66. PubMed ID: 26104682
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-200a and microRNA-141 have a synergetic effect on the suppression of epithelial-mesenchymal transition in liver cancer by targeting STAT4.
Chen S; Zhang J; Chen Q; Cheng J; Chen X; Mao Y; Chen W; Liu C; Wu H; Lv Y; Lin Y
Oncol Lett; 2021 Feb; 21(2):137. PubMed ID: 33552256
[TBL] [Abstract][Full Text] [Related]
35. Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya.
Ndede I; Mining SK; Patel K; Wanjala FM; Tenge C
Afr Health Sci; 2019 Dec; 19(4):3242-3248. PubMed ID: 32127902
[TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.
Chen Z; Liu X; Hu Z; Wang Y; Liu M; Liu X; Li H; Ji R; Guo Q; Zhou Y
Oncol Lett; 2015 Jul; 10(1):329-336. PubMed ID: 26171025
[TBL] [Abstract][Full Text] [Related]
37. Novel microRNAs expression of patients with chemotherapy drug-resistant and chemotherapy-sensitive epithelial ovarian cancer.
Liu L; Zou J; Wang Q; Yin FQ; Zhang W; Li L
Tumour Biol; 2014 Aug; 35(8):7713-7. PubMed ID: 24805828
[TBL] [Abstract][Full Text] [Related]
38. Transcription Factor YY1 Ameliorates Liver Ischemia-reperfusion Injury Through Modulating the miR-181a-5p/ESR1/ERBB2 Axis.
Wu K; Ma L; Xu T; Cao J; Zhou C; Yu X; Wang Y; Wen H
Transplantation; 2023 Apr; 107(4):878-889. PubMed ID: 36413144
[TBL] [Abstract][Full Text] [Related]
39. miRNA-186 inhibits prostate cancer cell proliferation and tumor growth by targeting YY1 and CDK6.
Lu S; Wang MS; Chen PJ; Ren Q; Bai P
Exp Ther Med; 2017 Jun; 13(6):3309-3314. PubMed ID: 28587405
[TBL] [Abstract][Full Text] [Related]
40. Yin-Yang-1 decreases Fas-induced apoptosis in acute lymphoblastic leukemia under hypoxic conditions: its implications in immune evasion.
Martínez-Torres E; López-Pérez TV; Morales-Martínez M; Huerta-Yepez S
Bol Med Hosp Infant Mex; 2020; 77(4):186-194. PubMed ID: 32713953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
